(Q34480625)

English

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

Cecilia Magnusson

object named as

Cecilia Magnusson

2

0 references

object named as

Paul W Dickman

6

0 references

5

object named as

Per Hall

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Lena U Rosenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Emma Lindström

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sara Wedrén

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

17 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

R11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

https://scigraph.springernature.com/pub.10.1186/bcr1378

0 references

Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Postmenopausal estrogen and progestin use in relation to breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Epidemiology of contralateral breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Low-potency oestrogen and risk of endometrial cancer: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Reproductive risk factors for breast cancer by receptor status, histology, laterality and location

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Body size in different periods of life and breast cancer risk in post-menopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Risk of breast cancer in relation to reproductive factors in Denmark

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

6 July 2018

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Breast cancer and hormone-replacement therapy: the Million Women Study

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Trends in incidence rates of invasive lobular and ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Association of family history and other risk factors with breast cancer risk (Sweden).

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Problems involved in including women with simple hysterectomy in epidemiologic studies measuring the effects of hormone replacement therapy on breast cancer risk

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

27 October 2018

Increase in lobular breast cancer incidence in Switzerland

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States)

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1413980

27 October 2018

Oral contraceptive use and risk of breast cancer by histologic type

1 reference

https://api.crossref.org/works/10.1186%2FBCR1378

21 January 2018

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy in relation to breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65–79 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refined morphologic criteria for tubular carcinoma to retain its favorable outcome status in contemporary breast carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of breast carcinoma III relationship of family history to tumor type

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estriol: absorption after long-term vaginal treatment and gastrointestinal absorption as influenced by a meal

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of previous benign breast disease for women with carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16507159

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR1378

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34480625&oldid=1552024219"